PRISYM ID’s Clinical Trial Solution Chosen for Medicines Manufacturing Innovation Centre Project

PRISYM ID’s Clinical Trial Solution Chosen for Medicines Manufacturing Innovation Centre Project

PRISYM ID’s compliant labelling solution, PRISYM 360, has been selected by CME Ltd to ensure delivery of just in time clinical trials  for the Medicines Manufacturing Innovation Centre project.

PRISYM ID, the leader in compliant labelling management solutions in the clinical trial supply chain, today announced that its life sciences dedicated labelling solution, PRISYM 360, will be part of a just in time clinical trials handling system comprising of a fully automated bottle filling, weighing, labelling, inspection and validation process for the Medicines Manufacturing Innovation Centre project. The solution was recommended to CME Ltd by one of the sponsors of the project.

Funded by UKRI and Scottish Enterprise, the Medicines Manufacturing Innovation Centre will be located in Renfrewshire, Scotland. It is led by CPI in partnership with the University of Strathclyde and founding industry partners, AstraZeneca and GlaxoSmithKline.

With PRISYM 360, the project will benefit from the use of the most up to date patient, drug and destination-specific label content which will ensure compliance, streamline processes, accelerate speed-to-market and maximise patient centricity.

According to CPI, the Medicines Manufacturing Innovation Centre aims to become an international beacon for innovation in small molecule medicines manufacturing, and will incorporate capabilities for development and manufacturing of drug substances and drug products in a GMP (Good Manufacturing Practice) - capable environment, which will help to ensure just in time, right first time and real time release manufacturing principles.

Paul Simmons, Engineering Director at CME Ltd comments:PRISYM ID were an obvious fit for the system because their solution is able to meet the very demanding requirements for print verification over a huge range of languages. The company is also very used to producing a fully validated system with full traceability - another key requirement for this system.”

Steve Ellison, VP of Clinical Trials at PRISYM ID comments: “We are thrilled to be part of such an exciting industry project and to contribute to innovations which will help bring new treatments to market more quickly for the benefit of patients. PRISYM 360 ensures that creation of the label content at time of print achieves the performance required for production in a GMP compliant just in time environment.”

This press release was published in Pharma Tech

Learn more about PRISYM ID Clinical Trial Solution:

Clinical Trials